Johnson & Johnson JNJ:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/13/24 EDT
151.00quote price arrow down-0.22 (-0.15%)
Volume
561,418
Close
151.22UNCH (UNCH)
Volume
5,062,315
52 week range
143.13 - 175.97
Loading...
  • Open150.04
  • Day High152.00
  • Day Low149.71
  • Prev Close151.22
  • 52 Week High175.97
  • 52 Week High Date08/10/23
  • 52 Week Low143.13
  • 52 Week Low Date04/18/24

Key Stats

  • Market Cap363.938B
  • Shares Out2.41B
  • 10 Day Average Volume7.71M
  • Dividend4.96
  • Dividend Yield3.28%
  • Beta0.53
  • YTD % Change-3.52

KEY STATS

  • Open150.04
  • Day High152.00
  • Day Low149.71
  • Prev Close151.22
  • 52 Week High175.97
  • 52 Week High Date08/10/23
  • 52 Week Low143.13
  • 52 Week Low Date04/18/24
  • Market Cap363.938B
  • Shares Out2.41B
  • 10 Day Average Volume7.71M
  • Dividend4.96
  • Dividend Yield3.28%
  • Beta0.53
  • YTD % Change-3.52

RATIOS/PROFITABILITY

  • EPS (TTM)6.69
  • P/E (TTM)22.61
  • Fwd P/E (NTM)14.31
  • EBITDA (TTM)31.292B
  • ROE (TTM)24.23%
  • Revenue (TTM)85.648B
  • Gross Margin (TTM)69.57%
  • Net Margin (TTM)19.93%
  • Debt To Equity (MRQ)48.03%

EVENTS

  • Earnings Date07/17/2024(est)
  • Ex Div Date05/20/2024
  • Div Amount1.24
  • Split Date-
  • Split Factor-

Related Video

Lightning Round: Hard pass on C3.ai, says Jim Cramer
VIDEO4:0404:04
Lightning Round: Hard pass on C3.ai, says Jim Cramer

Profile

MORE
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and...
Joaquin Duato
Chairman of the Board, Chief Executive Officer
Joseph Wolk
Chief Financial Officer, Executive Vice President
Tim Schmid
Executive Vice President, Worldwide Chairman of MedTech
Elizabeth Forminard
Executive Vice President, General Counsel
John Reed M.D., Ph.D.
Executive Vice President - Innovative Medicine, Research and Development
Address
One Johnson & Johnson Plaza
New Brunswick, NJ
08933
United States

Top Peers

SYMBOLLASTCHG%CHG
MRK
Merck & Co Inc
129.29UNCHUNCH
ABBV
AbbVie Inc
161.28UNCHUNCH
AZN
AstraZeneca PLC
77.43UNCHUNCH
RHHBY
Roche Holding AG
30.35-0.60-1.94%
NVS
Novartis AG
102.26UNCHUNCH